search
Back to results

Feasibility and Acceptability of Non Weight-bearing Physical Activity for People With Diabetic Foot Ulceration (DB-ACTIV)

Primary Purpose

Diabetic Foot, Cardiopulmonary, Physical Inactivity

Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Non weight-bearing physical activity program
Sponsored by
Université du Québec à Trois-Rivières
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Diabetic Foot

Eligibility Criteria

18 Years - 75 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

For individuals with a diabetic foot ulcer: Inclusion: Male or female Aged over 18 up to 75 years Willing to engage in PA (physical activity) Committed to following wound care recommendations to the best of their ability for the duration of the study Understand and read French. Exclusion: Uncontrolled DFU infection Use of a non-removable offloading modality (total contact cast) Uncontrolled hyperglycemia (HbA1c ≥ 10.0% or fasting blood glucose ≥ 16.0 mmol/L for ≥ 2 consecutive days) confirmed by blood sample results during the initial assessment or access to recent blood test results (within the last 3 months) or the log of home capillary blood glucose readings Participation in sports or regular intense physical activities (≥ 2 times per week) The following pre-existing heart problems: a cardiovascular event (myocardial infarction, heart surgery, etc.) in the last 3 months, unstable cardiovascular disease (uncontrolled hypertension, i.e., ≥ 160/90 mmHg, uncompensated heart failure, etc.), chest pain and exertional dyspnea and/or uninvestigated intermittent claudication Recent neurovascular problem (stroke, transient ischemic attack, etc.) in the last 3 months Health problem that the research team considers a contraindication to participating in the study Diabetes complication making moderate-intensity PA unsafe, such as untreated proliferative diabetic retinopathy or a sensitivity disorder to hypoglycemia, critical ischemia of one or both lower limbs. For kinesiologists: Inclusion: Have completed a bachelor's degree in kinesiology Understand, read, and speak French. Exclusion: None

Sites / Locations

    Arms of the Study

    Arm 1

    Arm Type

    Experimental

    Arm Label

    Physical activity

    Arm Description

    Adults 18 to 75 with an active diabetic foot ulcer

    Outcomes

    Primary Outcome Measures

    Feasibility of physical activity intervention
    Physical activity logbook, number of sessions completed with higher number meaning a greater feasibility
    Acceptability of physical activity intervention
    Treatment Acceptability and Preference (TAP) Questionnaire, minimum score 0/maximum score 16 with higher score meaning a greater acceptability
    Satisfaction towards physical activity intervention
    Client Satisfaction Questionnaire (CSQ-8), minimum score 8/maximum score 32 with higher score meaning a higher satisfaction

    Secondary Outcome Measures

    Estimated VO2max
    submaximal exercise test on a stationary bike (Aerobic Power Index submaximal exercise test), mL/kg/min
    Average daily step count over seven days
    At the waist and in the offloading boot using a FitBit Zip, number of steps
    Physical activity level
    Global Physical Activity Questionnaire (GPAQ), no minimum/maximum, details number of minutes/number of days per week of physical activity according to type of activity (work, leisures, commute, sedentary time)
    Height
    Standing with rigid measuring rod, cm
    Weight
    Standing on beam balance scale, kg
    Waist circumference
    With flexible measuring tape above ombilic, cm
    Body fat percentage
    With bio-impedance balance, %
    Arterial blood pressure
    With automatic blood pressure monitor, mm Hg
    Resting heart rate
    With automatic blood pressure monitor, bpm
    Wound measurements (width, length, depth)
    With flexible ruler
    Classification of the ulcer
    Using SINBAD system, 6 categories graded 0 or 1 for a minimum of 0 and maximum of 6, with higher score meaning a more complicated ulcer
    Non fasting venous blood glucose
    With venipuncture, mmol/L
    Glycated hemoglobin
    With venipuncture, %
    Lipid profile (total cholesterol, low density lipoprotein, high density lipoprotein, triglycerides, non-HDL cholesterol)
    Venipuncture, g/L
    Neuropathic pain (if present)
    Neuropathic pain (DN4) Questionnaire, 10 yes/no questions, higher number of yes indicates more severe neuropathic pain
    Sleep apnea symptoms
    Epworth sleepiness scale, minimum score of 0/maximum score of 24, higher score makes sleep apnea more likely
    Reported quality of life
    Quality of life questionnaire (EQ-5D-5L), minimum score of 5/maximum of 25 + 10cm visual analog scale, higher score represents a lower quality of life + 10cm being the best health condition possible
    Questionnaire on motivation to practice physical activity
    With the Behavioural Regulation in Exercise revised Questionnaire (BREQ-2), 5 motivation categories graded from 0 to 4, Intrinsic (4 questions), Identified (3 questions), Introjected (3 questions), External (4 questions) and Amotivation (4 questions), with lower scores meaning lesser motivation for each category

    Full Information

    First Posted
    January 16, 2023
    Last Updated
    October 17, 2023
    Sponsor
    Université du Québec à Trois-Rivières
    Collaborators
    Fondation Santé Trois-Rivières, Centre intégré universitaire de santé et services sociaux Mauricie et Centre-du-Québec (CIUSSS MCQ), Université de Montréal
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT06092827
    Brief Title
    Feasibility and Acceptability of Non Weight-bearing Physical Activity for People With Diabetic Foot Ulceration
    Acronym
    DB-ACTIV
    Official Title
    Feasibility and Acceptability Study of a Non Weight-bearing Physical Activity Program for People With Diabetic Foot Ulceration (DB ACTIV)
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    October 2023
    Overall Recruitment Status
    Not yet recruiting
    Study Start Date
    November 1, 2023 (Anticipated)
    Primary Completion Date
    June 30, 2024 (Anticipated)
    Study Completion Date
    June 30, 2024 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Université du Québec à Trois-Rivières
    Collaborators
    Fondation Santé Trois-Rivières, Centre intégré universitaire de santé et services sociaux Mauricie et Centre-du-Québec (CIUSSS MCQ), Université de Montréal

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    Intervention in the form of a PA (physical activity) program combining aerobic, resistance, and flexibility exercises adapted for wearing a lower limb offloading device and limiting weight-bearing on the feet, with a duration of twelve (12) weeks, consisting of two supervised sessions and one unsupervised home session per week.
    Detailed Description
    Objectives: Evaluate the acceptability of a non-weight bearing physical activity (PA) program; Assess the feasibility of the PA program and the data collection procedure; Evaluate the feasibility of a submaximal exercise test for cardiorespiratory capacity; and Verify the sensitivity of dependent variables to respond to a physical activity program (e.g., cardiorespiratory capacity, cardiovascular and metabolic risk factors, quality of life, PA level). Type of study: Feasibility and acceptability study with a pre-post evaluative design. Intervention: Intervention in the form of a PA (physical activity) program combining aerobic, resistance, and flexibility exercises adapted for wearing a lower limb offloading device and limiting weight-bearing on the feet, with a duration of twelve (12) weeks, consisting of two supervised sessions and one unsupervised home session per week. Subjects: 10-12 persons with an active diabetic foot ulcer 2-3 kinesiologists Data collection: Sociodemographic and health questionnaire (age, sex, gender, marital status, education level, employment status, average annual family income, medical and health history, pharmacological and non-pharmacological treatments); Feasibility assessment: PA (physical activity) logbook including 1) the number of supervised and unsupervised sessions completed, 2) the duration of each session, 3) participation rate (number of patients recruited/number of eligible patients), 4) attrition rate (number of participants who completed the follow-ups/number of participants recruited), and 5) perceived facilitators and barriers; Acceptability assessment: 1) Treatment Acceptability and Preference (TAP) Questionnaire, seven to nine additional questions to assess the use of provided material resources and required safety checks (capillary blood glucose and wound inspection) and collection of participants' feedback, and 2) Client Satisfaction Questionnaire (CSQ-8); Assessment of the sensitivity of dependent variables to respond to the PA program*: 1) estimation of VO2max by a submaximal exercise test on a stationary bike (Aerobic Power Index submaximal exercise test), 2) average daily step count over seven days at the waist and in the offloading boot at times 0, 4, 8, and 12 weeks, 3) Global Physical Activity Questionnaire (GPAQ), 3) clinical examination (height, weight, body mass index, waist circumference, body fat percentage, blood pressure, resting heart rate, characteristics of the DFU and classification (SINBAD), 4) paraclinical examinations (venous blood glucose, glycated hemoglobin, lipid profile), 5) neuropathic pain questionnaire (DN4), 6) Epworth sleepiness scale, quality of life questionnaire (EQ-5D-5L), 7) questionnaire on motivation to practice PA. Health and safety parameter measurements: electrocardiogram, oxygen saturation, estimated glomerular filtration rate, urine albumin/creatinine ratio, complete blood count. Data collection at 24 and 36 weeks is also planned for participants who agree to be contacted after completing the 12-week PA program.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Diabetic Foot, Cardiopulmonary, Physical Inactivity

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Single Group Assignment
    Model Description
    Feasibility and acceptability study
    Masking
    None (Open Label)
    Allocation
    N/A
    Enrollment
    12 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    Physical activity
    Arm Type
    Experimental
    Arm Description
    Adults 18 to 75 with an active diabetic foot ulcer
    Intervention Type
    Behavioral
    Intervention Name(s)
    Non weight-bearing physical activity program
    Intervention Description
    12-week duration, 2 supervised trainings/week, 1 unsupervised home-based training/week Aerobic, resistance and flexibility exercises
    Primary Outcome Measure Information:
    Title
    Feasibility of physical activity intervention
    Description
    Physical activity logbook, number of sessions completed with higher number meaning a greater feasibility
    Time Frame
    At time 12 weeks
    Title
    Acceptability of physical activity intervention
    Description
    Treatment Acceptability and Preference (TAP) Questionnaire, minimum score 0/maximum score 16 with higher score meaning a greater acceptability
    Time Frame
    At time 12 weeks
    Title
    Satisfaction towards physical activity intervention
    Description
    Client Satisfaction Questionnaire (CSQ-8), minimum score 8/maximum score 32 with higher score meaning a higher satisfaction
    Time Frame
    At time 12 weeks
    Secondary Outcome Measure Information:
    Title
    Estimated VO2max
    Description
    submaximal exercise test on a stationary bike (Aerobic Power Index submaximal exercise test), mL/kg/min
    Time Frame
    At times 0 and 12 weeks
    Title
    Average daily step count over seven days
    Description
    At the waist and in the offloading boot using a FitBit Zip, number of steps
    Time Frame
    At times 0, 4, 8, and 12 weeks
    Title
    Physical activity level
    Description
    Global Physical Activity Questionnaire (GPAQ), no minimum/maximum, details number of minutes/number of days per week of physical activity according to type of activity (work, leisures, commute, sedentary time)
    Time Frame
    At times 0 and 12 weeks
    Title
    Height
    Description
    Standing with rigid measuring rod, cm
    Time Frame
    At time 0
    Title
    Weight
    Description
    Standing on beam balance scale, kg
    Time Frame
    At times 0 and 12 weeks
    Title
    Waist circumference
    Description
    With flexible measuring tape above ombilic, cm
    Time Frame
    At times 0 and 12 weeks
    Title
    Body fat percentage
    Description
    With bio-impedance balance, %
    Time Frame
    At times 0 and 12 weeks
    Title
    Arterial blood pressure
    Description
    With automatic blood pressure monitor, mm Hg
    Time Frame
    At times 0 and 12 weeks
    Title
    Resting heart rate
    Description
    With automatic blood pressure monitor, bpm
    Time Frame
    At times 0 and 12 weeks
    Title
    Wound measurements (width, length, depth)
    Description
    With flexible ruler
    Time Frame
    At times 0, 4, 8 and 12 weeks
    Title
    Classification of the ulcer
    Description
    Using SINBAD system, 6 categories graded 0 or 1 for a minimum of 0 and maximum of 6, with higher score meaning a more complicated ulcer
    Time Frame
    At times 0, 4, 8 and 12 weeks
    Title
    Non fasting venous blood glucose
    Description
    With venipuncture, mmol/L
    Time Frame
    At times 0 and 12 weeks
    Title
    Glycated hemoglobin
    Description
    With venipuncture, %
    Time Frame
    At times 0 and 12 weeks
    Title
    Lipid profile (total cholesterol, low density lipoprotein, high density lipoprotein, triglycerides, non-HDL cholesterol)
    Description
    Venipuncture, g/L
    Time Frame
    At times 0 and 12 weeks
    Title
    Neuropathic pain (if present)
    Description
    Neuropathic pain (DN4) Questionnaire, 10 yes/no questions, higher number of yes indicates more severe neuropathic pain
    Time Frame
    At times 0 and 12 weeks
    Title
    Sleep apnea symptoms
    Description
    Epworth sleepiness scale, minimum score of 0/maximum score of 24, higher score makes sleep apnea more likely
    Time Frame
    At times 0 and 12 weeks
    Title
    Reported quality of life
    Description
    Quality of life questionnaire (EQ-5D-5L), minimum score of 5/maximum of 25 + 10cm visual analog scale, higher score represents a lower quality of life + 10cm being the best health condition possible
    Time Frame
    At times 0 and 12 weeks
    Title
    Questionnaire on motivation to practice physical activity
    Description
    With the Behavioural Regulation in Exercise revised Questionnaire (BREQ-2), 5 motivation categories graded from 0 to 4, Intrinsic (4 questions), Identified (3 questions), Introjected (3 questions), External (4 questions) and Amotivation (4 questions), with lower scores meaning lesser motivation for each category
    Time Frame
    At times 0 and 12 weeks
    Other Pre-specified Outcome Measures:
    Title
    Resting electrocardiogram (safety parameter)
    Description
    To detect ST-T abnormalities at rest which has been shown to be most predictive for silent ischemia
    Time Frame
    At time 0
    Title
    Estimated glomerular filtration rate (safety parameter)
    Description
    With venipuncture, mL/min. Results lower than 15 mL/min will need a specialist consultation to get medical clearance
    Time Frame
    At times 0 and 12 weeks
    Title
    Urine albumin/creatinine ratio (safety parameter)
    Description
    With urinalysis, mg/g. Results lower than 300 mg/g will need a specialist consultation to get medical clearance
    Time Frame
    At times 0 and 12 weeks
    Title
    Hemoglobin (safety parameter)
    Description
    With venipuncture, g/L. Results lower than 100 g/L will need a specialist consultation to get medical clearance
    Time Frame
    At times 0 and 12 weeks

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Maximum Age & Unit of Time
    75 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    For individuals with a diabetic foot ulcer: Inclusion: Male or female Aged over 18 up to 75 years Willing to engage in PA (physical activity) Committed to following wound care recommendations to the best of their ability for the duration of the study Understand and read French. Exclusion: Uncontrolled DFU infection Use of a non-removable offloading modality (total contact cast) Uncontrolled hyperglycemia (HbA1c ≥ 10.0% or fasting blood glucose ≥ 16.0 mmol/L for ≥ 2 consecutive days) confirmed by blood sample results during the initial assessment or access to recent blood test results (within the last 3 months) or the log of home capillary blood glucose readings Participation in sports or regular intense physical activities (≥ 2 times per week) The following pre-existing heart problems: a cardiovascular event (myocardial infarction, heart surgery, etc.) in the last 3 months, unstable cardiovascular disease (uncontrolled hypertension, i.e., ≥ 160/90 mmHg, uncompensated heart failure, etc.), chest pain and exertional dyspnea and/or uninvestigated intermittent claudication Recent neurovascular problem (stroke, transient ischemic attack, etc.) in the last 3 months Health problem that the research team considers a contraindication to participating in the study Diabetes complication making moderate-intensity PA unsafe, such as untreated proliferative diabetic retinopathy or a sensitivity disorder to hypoglycemia, critical ischemia of one or both lower limbs. For kinesiologists: Inclusion: Have completed a bachelor's degree in kinesiology Understand, read, and speak French. Exclusion: None
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Magali Brousseau-Foley, MD
    Phone
    819-372-5011
    Ext
    3782
    Email
    magali.brousseau-foley@uqtr.ca
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Magali Brousseau-Foley, MD
    Organizational Affiliation
    Université du Québec à Trois-Rivières
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Plan to Share IPD
    No
    Citations:
    PubMed Identifier
    27255501
    Citation
    Liubaoerjijin Y, Terada T, Fletcher K, Boule NG. Effect of aerobic exercise intensity on glycemic control in type 2 diabetes: a meta-analysis of head-to-head randomized trials. Acta Diabetol. 2016 Oct;53(5):769-81. doi: 10.1007/s00592-016-0870-0. Epub 2016 Jun 2.
    Results Reference
    background
    PubMed Identifier
    23160642
    Citation
    Umpierre D, Ribeiro PA, Schaan BD, Ribeiro JP. Volume of supervised exercise training impacts glycaemic control in patients with type 2 diabetes: a systematic review with meta-regression analysis. Diabetologia. 2013 Feb;56(2):242-51. doi: 10.1007/s00125-012-2774-z. Epub 2012 Nov 16.
    Results Reference
    background
    PubMed Identifier
    21540423
    Citation
    Umpierre D, Ribeiro PA, Kramer CK, Leitao CB, Zucatti AT, Azevedo MJ, Gross JL, Ribeiro JP, Schaan BD. Physical activity advice only or structured exercise training and association with HbA1c levels in type 2 diabetes: a systematic review and meta-analysis. JAMA. 2011 May 4;305(17):1790-9. doi: 10.1001/jama.2011.576.
    Results Reference
    background
    PubMed Identifier
    23185314
    Citation
    Balducci S, Zanuso S, Cardelli P, Salvi L, Bazuro A, Pugliese L, Maccora C, Iacobini C, Conti FG, Nicolucci A, Pugliese G; Italian Diabetes Exercise Study (IDES) Investigators. Effect of high- versus low-intensity supervised aerobic and resistance training on modifiable cardiovascular risk factors in type 2 diabetes; the Italian Diabetes and Exercise Study (IDES). PLoS One. 2012;7(11):e49297. doi: 10.1371/journal.pone.0049297. Epub 2012 Nov 21.
    Results Reference
    background
    PubMed Identifier
    21525503
    Citation
    Chudyk A, Petrella RJ. Effects of exercise on cardiovascular risk factors in type 2 diabetes: a meta-analysis. Diabetes Care. 2011 May;34(5):1228-37. doi: 10.2337/dc10-1881.
    Results Reference
    background
    PubMed Identifier
    27990609
    Citation
    Cai H, Li G, Zhang P, Xu D, Chen L. Effect of exercise on the quality of life in type 2 diabetes mellitus: a systematic review. Qual Life Res. 2017 Mar;26(3):515-530. doi: 10.1007/s11136-016-1481-5. Epub 2016 Dec 18.
    Results Reference
    background
    PubMed Identifier
    16735074
    Citation
    Nielsen PJ, Hafdahl AR, Conn VS, Lemaster JW, Brown SA. Meta-analysis of the effect of exercise interventions on fitness outcomes among adults with type 1 and type 2 diabetes. Diabetes Res Clin Pract. 2006 Nov;74(2):111-20. doi: 10.1016/j.diabres.2006.03.033. Epub 2006 Jun 2.
    Results Reference
    background
    PubMed Identifier
    10766678
    Citation
    Wei M, Gibbons LW, Kampert JB, Nichaman MZ, Blair SN. Low cardiorespiratory fitness and physical inactivity as predictors of mortality in men with type 2 diabetes. Ann Intern Med. 2000 Apr 18;132(8):605-11. doi: 10.7326/0003-4819-132-8-200004180-00002.
    Results Reference
    background
    PubMed Identifier
    32176447
    Citation
    Schaper NC, van Netten JJ, Apelqvist J, Bus SA, Hinchliffe RJ, Lipsky BA; IWGDF Editorial Board. Practical Guidelines on the prevention and management of diabetic foot disease (IWGDF 2019 update). Diabetes Metab Res Rev. 2020 Mar;36 Suppl 1:e3266. doi: 10.1002/dmrr.3266.
    Results Reference
    background
    PubMed Identifier
    28614678
    Citation
    Armstrong DG, Boulton AJM, Bus SA. Diabetic Foot Ulcers and Their Recurrence. N Engl J Med. 2017 Jun 15;376(24):2367-2375. doi: 10.1056/NEJMra1615439. No abstract available.
    Results Reference
    background
    Citation
    Agence de la santé publique du Canada (ASPC). Le diabète au Canada : Perspective de santé publique sur les faits et chiffres 2011 [Available from: https://www.canada.ca/fr/sante-publique/services/maladies-chroniques/rapports-publications/diabete/diabete-canada-perspective-sante-publique-faits-chiffres.html.
    Results Reference
    background
    PubMed Identifier
    15644549
    Citation
    Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA. 2005 Jan 12;293(2):217-28. doi: 10.1001/jama.293.2.217.
    Results Reference
    background
    PubMed Identifier
    26340966
    Citation
    van Netten JJ, Price PE, Lavery LA, Monteiro-Soares M, Rasmussen A, Jubiz Y, Bus SA; International Working Group on the Diabetic Foot. Prevention of foot ulcers in the at-risk patient with diabetes: a systematic review. Diabetes Metab Res Rev. 2016 Jan;32 Suppl 1:84-98. doi: 10.1002/dmrr.2701.
    Results Reference
    background
    PubMed Identifier
    17091370
    Citation
    Ribu L, Hanestad BR, Moum T, Birkeland K, Rustoen T. A comparison of the health-related quality of life in patients with diabetic foot ulcers, with a diabetes group and a nondiabetes group from the general population. Qual Life Res. 2007 Mar;16(2):179-89. doi: 10.1007/s11136-006-0031-y. Epub 2006 Nov 8.
    Results Reference
    background
    PubMed Identifier
    25608648
    Citation
    Hopkins RB, Burke N, Harlock J, Jegathisawaran J, Goeree R. Economic burden of illness associated with diabetic foot ulcers in Canada. BMC Health Serv Res. 2015 Jan 22;15:13. doi: 10.1186/s12913-015-0687-5.
    Results Reference
    background
    Citation
    Bissonnette V. Évaluation des coûts et éléments d'efficacité du traitement d'un ulcère du pied diabétique [Mémoire de maîtrise]: Université de Sherbrooke; 2011.
    Results Reference
    background
    PubMed Identifier
    23294922
    Citation
    Pelletier C, Dai S, Roberts KC, Bienek A, Onysko J, Pelletier L. Report summary. Diabetes in Canada: facts and figures from a public health perspective. Chronic Dis Inj Can. 2012 Dec;33(1):53-4.
    Results Reference
    background
    PubMed Identifier
    26978655
    Citation
    Eldridge SM, Lancaster GA, Campbell MJ, Thabane L, Hopewell S, Coleman CL, Bond CM. Defining Feasibility and Pilot Studies in Preparation for Randomised Controlled Trials: Development of a Conceptual Framework. PLoS One. 2016 Mar 15;11(3):e0150205. doi: 10.1371/journal.pone.0150205. eCollection 2016.
    Results Reference
    background
    PubMed Identifier
    14723394
    Citation
    Wallman K, Goodman C, Morton A, Grove R, Dawson B. Test-retest reliability of the aerobic power index component of the tri-level fitness profile in a sedentary population. J Sci Med Sport. 2003 Dec;6(4):443-54. doi: 10.1016/s1440-2440(03)80270-0.
    Results Reference
    background
    PubMed Identifier
    16844410
    Citation
    Wallman KE, Campbell L. Test-retest reliability of the Aerobic Power Index submaximal exercise test in an obese population. J Sci Med Sport. 2007 Jun;10(3):141-6. doi: 10.1016/j.jsams.2006.05.024. Epub 2006 Jul 17.
    Results Reference
    background
    PubMed Identifier
    29650112
    Citation
    Diabetes Canada Clinical Practice Guidelines Expert Committee; Sigal RJ, Armstrong MJ, Bacon SL, Boule NG, Dasgupta K, Kenny GP, Riddell MC. Physical Activity and Diabetes. Can J Diabetes. 2018 Apr;42 Suppl 1:S54-S63. doi: 10.1016/j.jcjd.2017.10.008. No abstract available.
    Results Reference
    background
    PubMed Identifier
    27926890
    Citation
    Colberg SR, Sigal RJ, Yardley JE, Riddell MC, Dunstan DW, Dempsey PC, Horton ES, Castorino K, Tate DF. Physical Activity/Exercise and Diabetes: A Position Statement of the American Diabetes Association. Diabetes Care. 2016 Nov;39(11):2065-2079. doi: 10.2337/dc16-1728. No abstract available.
    Results Reference
    background
    Citation
    Borg G. Borg's perceived exertion and pain scales: Human kinetics; 1998.
    Results Reference
    background
    PubMed Identifier
    35085917
    Citation
    Thakur A, Sharma R, Sharma SK, Thakur K, Jelly P. Effect of buerger allen exercise on foot perfusion among patient with diabetes mellitus: A systematic review & meta-analysis. Diabetes Metab Syndr. 2022 Feb;16(2):102393. doi: 10.1016/j.dsx.2022.102393. Epub 2022 Jan 13.
    Results Reference
    background
    PubMed Identifier
    19434647
    Citation
    Sidani S, Epstein DR, Bootzin RR, Moritz P, Miranda J. Assessment of preferences for treatment: validation of a measure. Res Nurs Health. 2009 Aug;32(4):419-31. doi: 10.1002/nur.20329.
    Results Reference
    background
    PubMed Identifier
    26684758
    Citation
    Evenson KR, Goto MM, Furberg RD. Systematic review of the validity and reliability of consumer-wearable activity trackers. Int J Behav Nutr Phys Act. 2015 Dec 18;12:159. doi: 10.1186/s12966-015-0314-1.
    Results Reference
    background
    PubMed Identifier
    10245370
    Citation
    Larsen DL, Attkisson CC, Hargreaves WA, Nguyen TD. Assessment of client/patient satisfaction: development of a general scale. Eval Program Plann. 1979;2(3):197-207. doi: 10.1016/0149-7189(79)90094-6. No abstract available.
    Results Reference
    background
    Citation
    Sabourin S, Pérusse D, Gendreau P. Les qualités psychométriques de la version canadienne-française du Questionnaire de Satisfaction du Consommateur de services psychothérapeutiques (QSC-8 et QSC-18B). Canadian Journal of Behavioural Science/Revue canadienne des sciences du comportement. 1989;21(2):147.
    Results Reference
    background
    PubMed Identifier
    19299344
    Citation
    Crews RT, Armstrong DG, Boulton AJ. A method for assessing off-loading compliance. J Am Podiatr Med Assoc. 2009 Mar-Apr;99(2):100-3. doi: 10.7547/0980100.
    Results Reference
    background
    Citation
    Armstrong T, Bull F. Development of the world health organization global physical activity questionnaire (GPAQ). Journal of Public Health. 2006;14:66-70.
    Results Reference
    background
    PubMed Identifier
    32429068
    Citation
    Fernandez-Torres R, Ruiz-Munoz M, Perez-Panero AJ, Garcia-Romero JC, Gonzalez-Sanchez M. Clinician Assessment Tools for Patients with Diabetic Foot Disease: A Systematic Review. J Clin Med. 2020 May 15;9(5):1487. doi: 10.3390/jcm9051487.
    Results Reference
    background
    PubMed Identifier
    22023377
    Citation
    Spallone V, Morganti R, D'Amato C, Greco C, Cacciotti L, Marfia GA. Validation of DN4 as a screening tool for neuropathic pain in painful diabetic polyneuropathy. Diabet Med. 2012 May;29(5):578-85. doi: 10.1111/j.1464-5491.2011.03500.x.
    Results Reference
    background
    PubMed Identifier
    1798888
    Citation
    Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991 Dec;14(6):540-5. doi: 10.1093/sleep/14.6.540.
    Results Reference
    background
    PubMed Identifier
    26627874
    Citation
    Matza LS, Boye KS, Stewart KD, Curtis BH, Reaney M, Landrian AS. A qualitative examination of the content validity of the EQ-5D-5L in patients with type 2 diabetes. Health Qual Life Outcomes. 2015 Dec 1;13:192. doi: 10.1186/s12955-015-0373-7.
    Results Reference
    background
    PubMed Identifier
    32266821
    Citation
    Ferrari M, Speight J, Beath A, Browne JL, Mosely K. The information-motivation-behavioral skills model explains physical activity levels for adults with type 2 diabetes across all weight classes. Psychol Health Med. 2021 Mar;26(3):381-394. doi: 10.1080/13548506.2020.1749292. Epub 2020 Apr 8.
    Results Reference
    background

    Learn more about this trial

    Feasibility and Acceptability of Non Weight-bearing Physical Activity for People With Diabetic Foot Ulceration

    We'll reach out to this number within 24 hrs